Synthesis of Arginase Inhibitors: An Overview

Area of Science:

• Biochemistry
• Enzymology
• Pharmacology

Background:

• Arginase (ARG) is a manganese metalloenzyme critical for the urea cycle and cellular processes.
• Two mammalian isoenzymes, ARG-1 and ARG-2, have distinct genetic and cellular properties.
• Aberrant ARG expression links to cardiovascular disease, inflammatory bowel disease, Alzheimer's disease, and cancer.

Purpose of the Study:

• To review existing arginase inhibitors.
• To provide synthesis protocols and reaction conditions for ARG inhibitors.
• To report IC50 values for ARG-1 and ARG-2 inhibition.

Main Methods:

• Comprehensive literature search for synthetic, natural, and semisynthetic ARG inhibitors.
• Detailed description of synthesis protocols and optimized reaction conditions.
• Reporting of IC50 values and assay types for ARG-1 and ARG-2 inhibition.

Main Results:

• Overview of diverse classes of ARG inhibitors.
• Detailed synthesis information, including patent-reported methods.
• Comparative IC50 data for ARG-1 and ARG-2 inhibition across various compounds.

Conclusions:

• Arginase inhibitors represent a promising therapeutic avenue for numerous diseases.
• This review consolidates critical information on ARG inhibitor synthesis and activity.
• Provides a valuable resource for developing novel ARG-targeted therapies.